These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 19164155)

  • 1. Distinct mode of interaction of a novel ketolide antibiotic that displays enhanced antimicrobial activity.
    Kouvela EC; Kalpaxis DL; Wilson DN; Dinos GP
    Antimicrob Agents Chemother; 2009 Apr; 53(4):1411-9. PubMed ID: 19164155
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Insights into the mode of action of novel fluoroketolides, potent inhibitors of bacterial protein synthesis.
    Krokidis MG; Márquez V; Wilson DN; Kalpaxis DL; Dinos GP
    Antimicrob Agents Chemother; 2014; 58(1):472-80. PubMed ID: 24189263
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Binding site of the bridged macrolides in the Escherichia coli ribosome.
    Xiong L; Korkhin Y; Mankin AS
    Antimicrob Agents Chemother; 2005 Jan; 49(1):281-8. PubMed ID: 15616307
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A ketolide resistance mutation in domain II of 23S rRNA reveals the proximity of hairpin 35 to the peptidyl transferase centre.
    Xiong L; Shah S; Mauvais P; Mankin AS
    Mol Microbiol; 1999 Jan; 31(2):633-9. PubMed ID: 10027979
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The macrolide-ketolide antibiotic binding site is formed by structures in domains II and V of 23S ribosomal RNA.
    Hansen LH; Mauvais P; Douthwaite S
    Mol Microbiol; 1999 Jan; 31(2):623-31. PubMed ID: 10027978
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ketolide antimicrobial activity persists after disruption of interactions with domain II of 23S rRNA.
    Novotny GW; Jakobsen L; Andersen NM; Poehlsgaard J; Douthwaite S
    Antimicrob Agents Chemother; 2004 Oct; 48(10):3677-83. PubMed ID: 15388419
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Binding site of macrolide antibiotics on the ribosome: new resistance mutation identifies a specific interaction of ketolides with rRNA.
    Garza-Ramos G; Xiong L; Zhong P; Mankin A
    J Bacteriol; 2001 Dec; 183(23):6898-907. PubMed ID: 11698379
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dissecting the ribosomal inhibition mechanism of a new ketolide carrying an alkyl-aryl group at C-13 of its lactone ring.
    Krokidis MG; Kostopoulou ON; Kalpaxis DL; Dinos GP
    Int J Antimicrob Agents; 2010 Mar; 35(3):235-9. PubMed ID: 20045632
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Macrolide-ketolide inhibition of MLS-resistant ribosomes is improved by alternative drug interaction with domain II of 23S rRNA.
    Douthwaite S; Hansen LH; Mauvais P
    Mol Microbiol; 2000 Apr; 36(1):183-93. PubMed ID: 10760175
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Binding and action of CEM-101, a new fluoroketolide antibiotic that inhibits protein synthesis.
    Llano-Sotelo B; Dunkle J; Klepacki D; Zhang W; Fernandes P; Cate JH; Mankin AS
    Antimicrob Agents Chemother; 2010 Dec; 54(12):4961-70. PubMed ID: 20855725
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Investigating the entire course of telithromycin binding to Escherichia coli ribosomes.
    Kostopoulou ON; Petropoulos AD; Dinos GP; Choli-Papadopoulou T; Kalpaxis DL
    Nucleic Acids Res; 2012 Jun; 40(11):5078-87. PubMed ID: 22362747
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structural insight into the antibiotic action of telithromycin against resistant mutants.
    Berisio R; Harms J; Schluenzen F; Zarivach R; Hansen HA; Fucini P; Yonath A
    J Bacteriol; 2003 Jul; 185(14):4276-9. PubMed ID: 12837804
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The emerging new generation of antibiotic: ketolides.
    Zhong P; Shortridge V
    Curr Drug Targets Infect Disord; 2001 Aug; 1(2):125-31. PubMed ID: 12455409
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structures of ketolides and macrolides determine their mode of interaction with the ribosomal target site.
    Douthwaite S; Champney WS
    J Antimicrob Chemother; 2001 Sep; 48 Suppl T1():1-8. PubMed ID: 11566971
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Design, synthesis and antibacterial activity of novel ketolides bearing an aryltetrazolyl-substituted alkyl side chain.
    Song QL; Guo BQ; Zhang W; Lan P; Sun PH; Chen WM
    J Antibiot (Tokyo); 2011 Aug; 64(8):571-81. PubMed ID: 21772308
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The slow dissociation rate of K-1602 contributes to the enhanced inhibitory activity of this novel alkyl-aryl-bearing fluoroketolide.
    Krokidis M; Bougas A; Stavropoulou M; Kalpaxis D; Dinos GP
    J Enzyme Inhib Med Chem; 2016; 31(2):276-82. PubMed ID: 25807301
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Design, synthesis and structure-activity relationships of novel macrolones: Hybrids of 2-fluoro 9-oxime ketolides and carbamoyl quinolones with highly improved activity against resistant pathogens.
    Ma CX; Lv W; Li YX; Fan BZ; Han X; Kong FS; Tian JC; Cushman M; Liang JH
    Eur J Med Chem; 2019 May; 169():1-20. PubMed ID: 30852383
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structural basis for the antibiotic activity of ketolides and azalides.
    Schlünzen F; Harms JM; Franceschi F; Hansen HA; Bartels H; Zarivach R; Yonath A
    Structure; 2003 Mar; 11(3):329-38. PubMed ID: 12623020
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Induction of erm(C) expression by noninducing antibiotics.
    Bailey M; Chettiath T; Mankin AS
    Antimicrob Agents Chemother; 2008 Mar; 52(3):866-74. PubMed ID: 18086834
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structures of the Escherichia coli ribosome with antibiotics bound near the peptidyl transferase center explain spectra of drug action.
    Dunkle JA; Xiong L; Mankin AS; Cate JH
    Proc Natl Acad Sci U S A; 2010 Oct; 107(40):17152-7. PubMed ID: 20876128
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.